AbCellera Biologics (STU:8QQ) Buildings And Improvements : €49.02 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is AbCellera Biologics Buildings And Improvements?

AbCellera Biologics's quarterly buildings and improvements declined from Sep. 2024 (€60.29 Mil) to Dec. 2024 (€50.53 Mil) and declined from Dec. 2024 (€50.53 Mil) to Mar. 2025 (€49.02 Mil).

AbCellera Biologics's annual buildings and improvements increased from Dec. 2022 (€10.73 Mil) to Dec. 2023 (€40.30 Mil) and increased from Dec. 2023 (€40.30 Mil) to Dec. 2024 (€50.53 Mil).

AbCellera Biologics Buildings And Improvements Historical Data

The historical data trend for AbCellera Biologics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbCellera Biologics Buildings And Improvements Chart

AbCellera Biologics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

1.07

10.73

40.30

50.53

AbCellera Biologics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															49.13	58.64	60.29	50.53	49.02

AbCellera Biologics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

AbCellera Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AbCellera Biologics Inc (STU:8QQ) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

ABCL:USA 8QQ:Germany

Address

150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6

Website

https://www.abcellera.com

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

AbCellera Biologics Headlines

No Headlines